Novo-Bupropion (bupropion) Treatment Report
Generic Name: Bupropion
What is Novo-Bupropion?
Novo-Bupropion is a Canadian brand name for bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used to treat major depressive disorder, including seasonal affective disorder (SAD) and as an adjunct in smoking cessation.
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| counter MS/Avonex induced depression | 1 | 0 |
Mouse over the table for more information
Currently Taking Novo-Bupropion
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 22, 2009.